loader
Please Wait
Applying Filters...

Athena Athena

X

Approved Drug Products containing 20725 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ABBVIE (5)

filter

01 CAPSULE, DELAYED RELEASE;ORAL (5)

filter

01 Blank (5)

filter

01 CREON (5)

filter

01 Blank (5)

URL Supplier Web Content
CAPSULE, DELAYED R...
180,000USP UNITS;3...
20725
CREON
Abbvie Company Banner

2024 ACI Convention

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
CAPSULE, DELAYED R...
120,000USP UNITS;2...
20725
CREON
Abbvie Company Banner

2024 ACI Convention

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
CAPSULE, DELAYED R...
30,000USP UNITS;6,...
20725
CREON
Abbvie Company Banner

2024 ACI Convention

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
CAPSULE, DELAYED R...
15,000USP UNITS;3,...
20725
CREON
Abbvie Company Banner

2024 ACI Convention

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
CAPSULE, DELAYED R...
60,000USP UNITS;12...
20725
CREON
Abbvie Company Banner

2024 ACI Convention

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 20725

Looking for FDA Orange Book APPLICATION 20725 5

19

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.

With a dosage strength 180,000USP UNITS;36,000USP UNITS;114,000USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

18

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.

With a dosage strength 120,000USP UNITS;24,000USP UNITS;76,000USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

17

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.

With a dosage strength 30,000USP UNITS;6,000USP UNITS;19,000USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

16

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.

With a dosage strength 15,000USP UNITS;3,000USP UNITS;9,500USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

15

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.

With a dosage strength 60,000USP UNITS;12,000USP UNITS;38,000USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

Post Enquiry
POST ENQUIRY